<DOC>
	<DOCNO>NCT01079598</DOCNO>
	<brief_summary>The purpose study demonstrate patient improve immediate treatment outcome successive radiofrequency ablation ( RFA ) incompetent perforator vein ( IPVs ) .</brief_summary>
	<brief_title>RFS - Radiofrequency Perforator Vein Treatment Study</brief_title>
	<detailed_description>The purpose study demonstrate patient competent great saphenous vein ( GSV ) short saphenous vein ( SSV ) undergone prior successful endovenous treatment incompetent GSV and/or SSV continue demonstrate clinical symptom peripheral venous insufficiency result incompetent perforator vein ( IPVs ) improve immediate treatment outcome successive radiofrequency ablation ( RFA ) IPVs vein .</detailed_description>
	<mesh_term>Venous Insufficiency</mesh_term>
	<criteria>Male female , age 18 80 year , racial ethnic origin Have ability understand requirement study , provide write informed consent participate , agree abide study requirement Available followup visit physical condition allow ambulation procedure Incompetent GSV and/or SSV target limb treat least 3 month study enrollment competent GSV SSV time treatment CEAP 4 6 classification DUS reflux ≥0.35 sec target IPV and/or intrafascia diameter ≥0.3 mm Acute ( Screening ) superficial venous thrombosis either limb Acute ( within prior 3 month ) deep venous thrombosis phlebitis either limb Complete near complete deep venous obstruction document ultrasound Previously participate study involve ClosureRFS Actively participate investigational study within 30 day enrollment study Pregnant time treatment . Status verify pregnancy test via blood urine woman ≤ 55 year old . Having medical condition , serious intercurrent illness , extenuate circumstance would significantly decrease study compliance , include require study followup Have condition , opinion Investigator , would jeopardize safety patient affect validity trial result Have history excessive alcohol consumption use illegal drug render patient unreliable , risk trial Have undergone major surgery may result abnormality target body area , reasonably suspect compromise study outcome Have undergone invasive procedure target body area ( e.g. , needle biopsy surgical procedure ) within 30 day enrollment study Known incompatibility , allergic reaction anesthetic use incompetent perforator vein treatment Patients require hyperbaric therapy involve treat limb 6 month post treatment followup period Great toe pressure measurement ≤ 70 mmHg CEAP 6 classify patient receive high dose steroid medication follow medication interfere normal mechanism wound healing , e.g . glucocorticoid , nonsteroidal antiinflammatory drug ( NSAIDs ) , antineoplastic immunosuppressive drug , others like , colchicine penicillamine . Expressing body mass index ( BMI ) ≥ 35 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>IPV</keyword>
	<keyword>RadioFrequency</keyword>
	<keyword>QOL</keyword>
</DOC>